Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02286102 · ClinicalTrials.gov registry record · NA
A Prospective Randomized Study on the Clinical Benefits of OrthoPAT Drains
A NA study, sponsored by Hospital for Special Surgery, New York.
- Completed
- Registry status
- NA
- Development phase
- 70
- Enrollment target
NCT02286102 is a NA study that has completed, run by Hospital for Special Surgery, New York. The registered enrollment target is 70 participants.
The verdict
NCT02286102, a NA study, has completed, sponsored by Hospital for Special Surgery, New York.
- COMPLETED
- Registry status
- NA
- Development phase
- 70 participants
- Enrollment target
Study Summary
The examination of the ability of the OrthoPAT® blood collection device to decrease the transfusion rate and volume of adults undergoing posterior spine surgery for deformity correction of 6 levels or more.
Interventions
- DEVICE OrthoPAT
- DEVICE Constavac
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 70 participants |
| Start Date | 2011-01 |
| Est. Completion | 2016-10-17 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02286102
The ClinicalTrials.gov registry entry for NCT02286102 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 70 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Hospital for Special Surgery, New York, which has 194 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which OrthoPAT is the first listed.
NCT02286102 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02286102 about?
NCT02286102 is a clinical study titled "A Prospective Randomized Study on the Clinical Benefits of OrthoPAT Drains". The examination of the ability of the OrthoPAT® blood collection device to decrease the transfusion rate and volume of adults undergoing posterior spine surgery for deformity correction of 6 levels or more.
What is the current status of trial NCT02286102?
This trial is currently completed. It is a NA study. The enrollment target is 70 participants. The study started on 2011-01. Estimated completion is 2016-10-17.
What interventions are being tested in trial NCT02286102?
The interventions under investigation include: OrthoPAT (DEVICE), Constavac (DEVICE).
Who is sponsoring clinical trial NCT02286102?
This trial is sponsored by Hospital for Special Surgery, New York, which has 194 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.